About the Authors

Thomas A. Rasmussen

thomrasm@rm.dk

Affiliation Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark

Danny Jensen

Affiliation Department of Nephrology, Aarhus University Hospital and Institute of Biomedicine, Aarhus University, Aarhus, Denmark

Martin Tolstrup

Affiliation Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark

Ulla S. Nielsen

Affiliation Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark

Erland J. Erlandsen

Affiliation Department of Clinical Biochemistry, Viborg Regional Hospital, Viborg, Denmark

Henrik Birn

Affiliation Department of Nephrology, Aarhus University Hospital and Institute of Biomedicine, Aarhus University, Aarhus, Denmark

Lars Østergaard

Affiliation Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark

Bente L. Langdahl

Affiliation Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark

Alex L. Laursen

Affiliation Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark

Competing Interests

The study was supported by a grant of US$ 9,100 from GlaxoSmithKline (www.gsk.com). Lars Østergaard has received consultancy and speaker's fee from: Abbott, MSD, Pfizer, Bristol-Meyer Squibb, GlaxoSmithKline, ViiV Healthcare, Gilead, and Tibotec. Alex L Laursen has served on the advisory board for GlaxoSmithKline, Gilead, and Janssen. Lamivudine/zidovudine and abacavir/lamivudine are manufactured by GSK; tenofovir/emtricitabine is manufactured by Gilead. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: TAR MT LØ ALL USN. Performed the experiments: DJ HB EJE BLL. Analyzed the data: TAR ALL LØ HB. Contributed reagents/materials/analysis tools: EJE HB DJ BLL. Wrote the paper: TAR ALL HB BLL.